Innospec Inc. cash flow to debt ratio of 262.43% indicates that the company generates enough cash to cover a substantial portion of its debt. This level indicates very strong financial health.

Innospec Inc.'s free cash flow has decreased 38.50% from $143.10M last year to $88.00M, signaling decreasing performance

Innospec Inc.'s debt to equity ratio is 0.04, which means that the company's assets are healthy financed, signaling financial stability.

Innospec Inc.'s debt has increased relative to shareholder equity from 0.04 last year to 0.04 today, signaling weakened financials

Innospec Inc. has a net cash position, so leverage is healthy.

Innospec Inc. earns at least as much interest as it pays. Interest obligations are fully covered.

Innospec Inc.'s profit margin has increased (241.90%) in the last year from 1.93% to 6.60%, signaling increasing performance

Innospec Inc.'s short-term assets of $1.00B exceed its short-term liabilities of $360.10M

Innospec Inc.'s return on assets of 6.58% is higher than the 5.00% threshold, indicating efficient asset utilization

Innospec Inc.'s return on equity of 9.15%, is lower than 15.00%, indicating bad performance

Innospec Inc.'s operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation

Innospec Inc. had positive net income in 5 out of 5 years, indicating stable and consistent earnings

Innospec Inc. has positive free cash flow, indicating the company generates cash after capital expenditures

Innospec Inc. has a free cash flow yield of 3.85%, which is above the 2.00% threshold, indicating strong cash generation relative to market value

Innospec Inc.'s yearly earnings has increased 227.53% since last year from $35.60M to $116.60M, signaling increasing performance

Innospec Inc.'s yearly revenue has decreased 3.65% since last year from $1.85B to $1.78B, signaling decreasing performance

ROIC 8.56% (Source: FMP key-metrics). In the 5–10% partial-credit band. Score: 1 of 2. This band sits within the typical US weighted-average cost of capital range. Methodology choice can change the conclusion: under FMP's invested-capital definition the company is at or near its cost of capital; under narrower operating-capital definitions the same company may score higher. Invested capital here includes equity, non-current liabilities, and short-term debt. Cash is not subtracted. See methodology.

Innospec Inc.'s 3-year revenue CAGR of -3.26% is negative, indicating declining revenue over the past 3 years

Innospec Inc. had revenue growth in only 2 out of 5 years, indicating inconsistent revenue performance

Innospec Inc. had positive ROE in 5 out of 5 years, indicating consistent and reliable returns on equity

Innospec Inc. is overvalued relative to its fair value price of 40.86 based on Discounted Cash Flow model

Innospec Inc. has an earnings yield of 5.31%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings

Innospec Inc. is overvalued relative to its fair value price of 65.98 based on EBITDA multiple model

Innospec Inc. has an EV/EBITDA ratio of 10.93x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings

Innospec Inc. is undervalued relative to its fair value price of 121.31 based on Earnings Fair Value model

Innospec Inc. has a PEG-ratio under 1 which is considered undervalued

Innospec Inc. has a price-to-book ratio of 1.69x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value

Innospec Inc. has a price-to-sales ratio of 1.24x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue